FDA OKs 'Game Changer' Radiotracer for Prostate Cancer

(MedPage Today) -- WASHINGTON--The FDA approved the first PET imaging agent that targets prostate-specific membrane antigen (PSMA) for evaluation of men with suspected prostate cancer, a potential game-changing advance, according to experts...